MetroHealth System is a clinical research site located in Cleveland, Ohio, United States 44122.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
MetroHealth System has participated in 21 clinical trials with 4 currently active.
Therapeutic areas: Bipolar Depression, Screening Colonoscopy, Surveillance Colonoscopy.
Sponsors: Sumitomo Pharma America, Inc., Magentiq Eye LTD, Hoffmann-La Roche.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MetroHealth System has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MetroHealth System has 21 clinical trials on record, with 4 currently active. Their work covers Bipolar Depression, Screening Colonoscopy, Surveillance Colonoscopy.
Yes — MetroHealth System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.